Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Alaskan wildlife officials canceled the 2022-23 Bering Sea Snow Crab season for the first time ever. The Bristol Bay King Crab season is also canceled for the second consecutive year.
An economist says U.S. ag exports could fall next year due to several factors.
According to the latest Cattle on Feed report, drought brought placement numbers lower.
